Hoyoung Maeng
National Cancer Institute (NCI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hoyoung Maeng as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:26 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04491955 · Phase II Trial of Combination Immunotherapy in Subjects With Advanced Small Bowel and Colorectal CancersNational Cancer Institute (NCI) · completed · Small Bowel Cancers, Colorectal Cancers · principal investigator
- Ph1/Ph2NCT04247282 · Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus InfectionNational Cancer Institute (NCI) · completed · Head and Neck Cancer, Head and Neck Neoplasms · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:26 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Oxidative status in iron-deficiency anemia.J Clin Lab Anal · 200955 citationsRCR 1.6
- Long-term results of a phase II trial of lenalidomide plus prednisone therapy for patients with myelofibrosis.Leuk Res · 201618 citationsRCR 0.6
- Pharmacokinetic study of meropenem in healthy beagle dogs receiving intermittent hemodialysis.J Vet Pharmacol Ther · 20165 citationsRCR 0.3